U.S. markets close in 5 hours 30 minutes

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.86+0.16 (+1.17%)
As of 10:30AM EST. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
117
318
463
420
173
Cost of Revenue
43,003
52,866
41,382
33,931
14,538
Gross Profit
-42,886
-52,548
-40,919
-33,511
-14,365
Operating Expense
66,705
23,702
15,239
13,552
8,449
Operating Income
-109,591
-76,250
-56,158
-47,063
-22,814
Net Non Operating Interest Income Expense
1,636
2,663
2,234
702
27
Other Income Expense
-48,808
-50,115
-10,123
-24,431
-508
Pretax Income
-156,763
-123,702
-64,047
-70,792
-23,295
Tax Provision
-159
144
73
-
-
Net Income Common Stockholders
-156,604
-123,846
-64,120
-70,792
-23,295
Diluted NI Available to Com Stockholders
-156,604
-123,846
-64,120
-70,792
-23,295
Basic EPS
-
-0.0013
0
0
0
Diluted EPS
-
-0.0013
0
0
0
Basic Average Shares
-
93,024
84,782
76,948
35,285
Diluted Average Shares
-
93,024
84,782
76,948
35,285
Total Operating Income as Reported
-
-
-
-47,063
-
Rent Expense Supplemental
-
2,356
1,704
1,327
179
Total Expenses
109,708
76,568
56,621
47,483
22,987
Net Income from Continuing & Discontinued Operation
-156,604
-123,846
-64,120
-70,792
-23,295
Normalized Income
-115,783
-92,793
-56,680
-46,361
-22,787
Interest Income
1,849
2,702
2,234
1,040
27
Interest Expense
213
39
-
-
-
Net Interest Income
1,636
2,663
2,234
702
27
EBIT
-156,550
-123,663
-56,158
-47,063
-22,814
EBITDA
-154,761
-
-
-
-
Reconciled Cost of Revenue
43,003
52,866
41,382
33,931
14,538
Reconciled Depreciation
1,789
1,548
1,565
1,456
1,479
Net Income from Continuing Operation Net Minority Interest
-156,604
-123,846
-64,120
-70,792
-23,295
Total Unusual Items Excluding Goodwill
-40,862
-42,249
-10,123
-24,431
-508
Total Unusual Items
-40,862
-42,249
-10,123
-24,431
-508
Normalized EBITDA
-113,899
-79,866
-44,470
-21,176
-20,827
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-41.4451
-11,196
-2,683
0
0